Dowling & Yahnke LLC decreased its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 1.2% during the 3rd quarter, Holdings Channel reports. The firm owned 53,813 shares of the healthcare conglomerate’s stock after selling 636 shares during the period. UnitedHealth Group accounts for about 1.1% of Dowling & Yahnke LLC’s investment portfolio, making the stock its 14th largest holding. Dowling & Yahnke LLC’s holdings in UnitedHealth Group were worth $10,539,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Marshall Wace LLP boosted its holdings in shares of UnitedHealth Group by 441.4% during the second quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock worth $2,578,000 after purchasing an additional 11,361 shares during the last quarter. American Century Companies Inc. boosted its holdings in shares of UnitedHealth Group by 16.9% during the second quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock worth $872,051,000 after purchasing an additional 681,111 shares during the last quarter. Schwab Charles Investment Management Inc. boosted its holdings in shares of UnitedHealth Group by 5.3% during the second quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock worth $678,077,000 after purchasing an additional 183,401 shares during the last quarter. Essex Financial Services Inc. boosted its holdings in shares of UnitedHealth Group by 12.3% during the second quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock worth $1,640,000 after purchasing an additional 967 shares during the last quarter. Finally, Bainco International Investors boosted its holdings in shares of UnitedHealth Group by 5.4% during the third quarter. Bainco International Investors now owns 82,676 shares of the healthcare conglomerate’s stock worth $16,192,000 after purchasing an additional 4,202 shares during the last quarter. Institutional investors and hedge funds own 86.09% of the company’s stock.

UnitedHealth Group Inc (NYSE UNH) opened at $243.35 on Friday. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.70. UnitedHealth Group Inc has a 52-week low of $156.49 and a 52-week high of $244.35. The company has a market capitalization of $235,290.00, a PE ratio of 22.72, a price-to-earnings-growth ratio of 1.42 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. During the same period last year, the company posted $2.11 earnings per share. The firm’s revenue was up 9.5% compared to the same quarter last year. equities research analysts anticipate that UnitedHealth Group Inc will post 12.53 EPS for the current fiscal year.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Kenneth Irwin Shine sold 457 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total value of $96,440.71. The disclosure for this sale can be found here. Insiders sold 33,655 shares of company stock worth $7,469,083 over the last three months. 0.89% of the stock is currently owned by corporate insiders.

UNH has been the topic of several analyst reports. Goldman Sachs Group initiated coverage on UnitedHealth Group in a report on Wednesday, January 3rd. They set a “buy” rating and a $269.00 price objective on the stock. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. Morgan Stanley lifted their target price on UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a report on Wednesday, October 18th. Credit Suisse Group lifted their target price on UnitedHealth Group from $252.00 to $260.00 and gave the company an “outperform” rating in a report on Wednesday. Finally, ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Two analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $243.22.

TRADEMARK VIOLATION NOTICE: This report was published by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another publication, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this report can be read at https://www.dailypolitical.com/2018/01/21/dowling-yahnke-llc-has-10-54-million-stake-in-unitedhealth-group-inc-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.